We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

234 hedge funds and large institutions have $3.41B invested in Myriad Genetics in 2015 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 74 increasing their positions, 89 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

9% more capital invested

Capital invested by funds: $3.13B → $3.41B (+$282M)

3% more call options, than puts

Call options by funds: $33.7M | Put options by funds: $32.7M

0% more funds holding

Funds holding: 234 → 234 (0)

0% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 31

17% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 89

Holders
234
Holders Change
–
Holders Change %
0%
% of All Funds
6.53%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.14%
New
31
Increased
74
Reduced
89
Closed
31
Calls
$33.7M
Puts
$32.7M
Net Calls
+$1.04M
Net Calls Change
+$4.85M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.2M
2
FCM
Frontier Capital Management
Massachusetts
+$17.5M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$17.3M
4
RCMC
RK Capital Management (Colorado)
Colorado
+$15.1M
5
Northern Trust
Northern Trust
Illinois
+$14.5M

Top Sellers

1
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$28.5M
2
First Trust Advisors
First Trust Advisors
Illinois
-$22.8M
3
RA
Royce & Associates
New York
-$19.6M
4
IAM
Iridian Asset Management
Connecticut
-$18.6M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$18.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Baillie Gifford & Co
1
Baillie Gifford & Co
United Kingdom
$401M +$11M +311,000 +3%
Capital Research Global Investors
2
Capital Research Global Investors
California
$335M – – –
Capital World Investors
3
Capital World Investors
California
$330M -$4.68M -131,815 -1%
SCM
4
Scopia Capital Management
New York
$254M +$10.5M +297,026 +5%
IAM
5
Iridian Asset Management
Connecticut
$198M -$18.6M -522,777 -9%
Vanguard Group
6
Vanguard Group
Pennsylvania
$175M -$264K -7,432 -0.2%
First Trust Advisors
7
First Trust Advisors
Illinois
$138M -$22.8M -641,930 -15%
BFA
8
BlackRock Fund Advisors
California
$104M +$2.11M +59,360 +2%
RA
9
Royce & Associates
New York
$85.1M -$19.6M -551,535 -20%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$84.8M +$31.2M +878,893 +63%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$77.9M +$17.3M +486,307 +31%
State Street
12
State Street
Massachusetts
$71.7M -$7.14M -201,242 -10%
SCM
13
Sterling Capital Management
North Carolina
$69.2M -$3.93M -110,644 -6%
BIT
14
BlackRock Institutional Trust
California
$62.7M -$2.03M -57,307 -3%
FCM
15
Frontier Capital Management
Massachusetts
$61.1M +$17.5M +494,256 +44%
DGI
16
Disciplined Growth Investors
Minnesota
$51.7M +$557K +15,700 +1%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$45.6M +$2.86M +80,662 +7%
PA
18
Pinnacle Associates
New York
$37.6M -$1.02M -28,800 -3%
Northern Trust
19
Northern Trust
Illinois
$37.5M +$14.5M +409,092 +69%
Renaissance Technologies
20
Renaissance Technologies
New York
$32.1M +$7.69M +216,800 +34%
Invesco
21
Invesco
Georgia
$30.2M +$7.63M +214,915 +36%
CIM
22
Contrarius Investment Management
Jersey
$28M -$1.06M -29,972 -4%
BTS
23
BB&T Securities
Virginia
$27.4M +$490K +13,795 +2%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$26.4M -$2.54M -71,682 -9%
LSV Asset Management
25
LSV Asset Management
Illinois
$26.1M -$2.39M -67,230 -9%
1
2 3 4 5

MYGN Hedge Fund Activity: Q3 2015 in Review

234 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q3 2015, worth a combined $3.41B — up 9% from $3.13B a quarter earlier.

Fund positioning in MYGN was balanced in Q3 2015: 31 funds opened new positions, 31 closed out, 74 added to existing stakes and 89 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $31.2M. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $28.5M.

  • 234 institutional investors held Myriad Genetics (MYGN) as of Q3 2015, unchanged from Q2 2015.
  • Funds reported $3.41B of Myriad Genetics stock for Q3 2015, up 9% quarter-over-quarter.
  • 31 funds opened new Myriad Genetics positions in Q3 2015 and 31 closed out, a net change of 0 holders.
  • The largest Myriad Genetics buyer in Q3 2015 was Fidelity Investments, an estimated $31.2M added.
  • The largest Myriad Genetics seller in Q3 2015 was Manulife (Manufacturers Life Insurance), an estimated $28.5M sold.

Based on aggregated 13F filings for Q3 2015.